New specific migraine prevention: monoclonal antibodies against calcitonin gene-related peptide and its receptor
Migraine is a long-lasting neurological disorder with significant negative impact not only on the patient’s life, but also on society. For many years, preventive treatment of migraine included drugs developed for diseases other than migraine such as hypertension, depression, and epilepsy. During th...
Saved in:
Main Authors: | K. Ryliškienė, D. Jatužis, A. Vaitkus |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2019-12-01
|
Series: | Neurologijos seminarai |
Subjects: | |
Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/27765 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differentially localizing isoforms of the migraine component calcitonin gene-related peptide (CGRP), in the mouse trigeminal ganglion: βCGRP is translated but, unlike αCGRP, not sorted into axons
by: Sofia Lyng Wæver, et al.
Published: (2025-01-01) -
Erenumab effectiveness and safety: comparison of real-life data and clinical trial results
by: Austėja Dapkutė, et al.
Published: (2021-12-01) -
Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis
by: Daiki Tokuyasu, et al.
Published: (2025-01-01) -
Clinical Pharmacokinetics of Atogepant in Healthy Japanese and White Adults
by: Ramesh R. Boinpally, et al.
Published: (2025-01-01) -
Estimation of calcitonin and calcitonin gene-related peptide-α in bone calcification in quail during laying period
by: Hadeel M. Hameed, et al.
Published: (2025-01-01)